These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24090940)

  • 1. Liver abnormalities in bowel diseases.
    Kummen M; Schrumpf E; Boberg KM
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):531-42. PubMed ID: 24090940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
    World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
    Bosch DE; Yeh MM
    Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    DeFilippis EM; Kumar S
    Dig Dis Sci; 2015 Oct; 60(10):2873-80. PubMed ID: 25999245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U; Shen B
    Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrence of chronic cholestatic liver diseases following liver transplantation].
    Cirera I
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():77-80. PubMed ID: 11968350
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatobiliary associations with inflammatory bowel disease.
    Knight C; Murray KF
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):681-91. PubMed ID: 19929587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary disorders and complications of inflammatory bowel disease.
    Venkatesh PG; Navaneethan U; Shen B
    J Dig Dis; 2011 Aug; 12(4):245-56. PubMed ID: 21791019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for cholestatic liver disease: screening and assessment of risk factors.
    Crippin JS
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S2-8. PubMed ID: 9742488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease, and Whipple's disease.
    Smyth C; Kelleher D; Keeling PW
    Clin Liver Dis; 2002 Nov; 6(4):1013-32. PubMed ID: 12516204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.
    Wiesner RH
    Mayo Clin Proc; 1998 Jun; 73(6):575-88. PubMed ID: 9621867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.
    Liu K; Strasser SI; Koorey DJ; Leong RW; Solomon M; McCaughan GW
    Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):949-960. PubMed ID: 28627935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Holtmeier J; Leuschner U
    Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary disease in inflammatory bowel disease.
    Ahmad J; Slivka A
    Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis.
    Williamson KD; Chapman RW
    Dig Dis; 2014; 32(4):438-45. PubMed ID: 24969292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic manifestations of inflammatory bowel diseases.
    Restellini S; Chazouillères O; Frossard JL
    Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.